Optimization of fermentation conditions for the production of recombinant feruloyl esterase BpFaeT132C−D143C
Folia Microbiologica · 2025
DOI: 10.1007/s12223-024-01197-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Microbiologica, 2025. Verfasst von Jinghao Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, 100048, China. Hauptthemen laut MEDLINE: Fermentation, Escherichia coli, Carboxylic Ester Hydrolases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Feruloyl esterases (FAEs) are a crucial component of the hemicellulose-degrading enzyme family that facilitates the degradation of lignocellulose while releasing hydroxycinnamic acids such as ferulic acid with high added value. Currently, the low enzyme yield of FAEs is one of the primary factors limiting its application. Therefore, in this paper, we optimized the fermentation conditions for the expression of FAE BpFaeT132C-D143C with excellent thermal stability in Escherichia coli by experimental design. Firstly, we explored the effects of 11 factors such as medium type, isopropyl-β-D-thiogalactopyranoside (IPTG) concentration, and inoculum size on BpFaeT132C-D143C activity separately by the single factor design. Then, the significance of the effects of seven factors, such as post-induction temperature, shaker rotational speed, and inoculum size on BpFaeT132C-D143C activity, was analyzed by Plackett-Burman design. We identified the main factors affecting the fermentation conditions of E. coli expressing BpFaeT132C-D143C as post-induction temperature, pre-induction period, and post-induction period. Finally, we used the steepest ascent path design and response surface method to optimize the levels of these three factors further. Under the optimal conditions, the activity of BpFaeT132C-D143C was 3.58 U/ml, which was a significant 6.6-fold increase compared to the pre-optimization (0.47 U/ml), demonstrating the effectiveness of this optimization process. Moreover, BpFaeT132C-D143C activity was 1.52 U/ml in a 3-l fermenter under the abovementioned optimal conditions. It was determined that the expression of BpFaeT132C-D143C in E. coli was predominantly intracellular in the cytoplasm. This study lays the foundation for further research on BpFaeT132C-D143C in degrading agricultural waste transformation applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, 100048, China.
- Beijing Engineering and Technology Research Center of Food Additives, Beijing Technology and Business University, Beijing, 100048, China.
- Key Laboratory of Geriatric Nutrition and Health (Beijing Technology and Business University), Ministry of Education, Beijing, 100048, China. fanguangsen@btbu.edu.cn.
- Key Laboratory of Green Manufacturing and Biosynthesis of Food Bioactive Substances, China General Chamber of Commerce, Beijing Technology and Business University, No. 11 Fucheng Street, Haidian District, Beijing, 10004…
Zitieren
APA
Ma, J., Basit, R. A., Yuan, S., Zhao, X., Liu, X., & Fan, G. (2025). Optimization of fermentation conditions for the production of recombinant feruloyl esterase BpFaeT132C−D143C. Folia Microbiologica. https://doi.org/10.1007/s12223-024-01197-6
Vancouver
Ma J, Basit RA, Yuan S, Zhao X, Liu X, Fan G. Optimization of fermentation conditions for the production of recombinant feruloyl esterase BpFaeT132C−D143C. Folia Microbiologica. 2025. doi:10.1007/s12223-024-01197-6
BibTeX
@article{Ma2025,
author = {Ma, Jinghao and Basit, Rana Abdul and Yuan, Sihan and Zhao, Xuan and Liu, Xiaoyan and Fan, Guangsen},
title = {Optimization of fermentation conditions for the production of recombinant feruloyl esterase BpFaeT132C−D143C},
journal = {Folia Microbiologica},
year = {2025},
doi = {10.1007/s12223-024-01197-6}
}
EUVIMED